Safety and effectiveness of apixaban in Japanese patients with nonvalvular atrial fibrillation in clinical practice: A regulatory postmarketing surveillance, the STANDARD study

Autor: Hiroshi Inoue, Michiaki Umeyama, Takako Yamada, Hiroyuki Hashimoto, Akira Komoto, Masahiro Yasaka

Publikováno v: Journal of Arrhythmia, Vol 35, Iss 3, Pp 506-514 (2019)

Abstract Background Apixaban, a non‐vitamin K oral anticoagulant (NOAC), was approved in Japan in 2012 for the prevention of thromboembolic events in patients with nonvalvular atrial fibrillation (NVAF). However, the safety and effectiveness of api

Externí odkaz: https://doaj.org/article/dee5bbb37348413b8ea5f89be46d0717

Safety and effectiveness of reduced-dose apixaban in Japanese patients with nonvalvular atrial fibrillation in clinical practice: A sub-analysis of the STANDARD study

Autor: Akira Komoto, Michiaki Umeyama, Hiroshi Inoue, Masahiro Yasaka, Hiroyuki Hashimoto, Takako Yamada

Publikováno v: Journal of Cardiology. 75:208-215

The safety and effectiveness of reduced-dose apixaban 2.5mg twice daily (BID) have not been elucidated thoroughly in Japanese patients with nonvalvular atrial fibrillation (NVAF).A post-marketing survey study included NVAF patients who newly initiate

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0dc51551bf16330e91e42bfd5355edf5
https://doi.org/10.1016/j.jjcc.2019.07.007

Real-world safety and efficacy data of ipilimumab in Japanese radically unresectable malignant melanoma patients: A postmarketing surveillance

Autor: Hisashi Uhara, Naoya Yamazaki, Naoki Shakunaga, Tetsuya Tsuchida, Akira Komoto, Yoshio Kiyohara, Eijun Itakura, Keiko Maruyama

Publikováno v: The Journal of Dermatology

Treatment with immune checkpoint inhibitors has improved prognosis among patients with cutaneous melanoma, but there are still unmet medical needs in Japan, especially for mucosal melanoma and acral lentiginous melanoma (ALM) subtypes. Ipilimumab, a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5d3164b0dc3435e75da8f063cd7fc7e
https://pubmed.ncbi.nlm.nih.gov/32515086

Corrigendum to 'Nationwide surveillance of bacterial respiratory pathogens conducted by the Surveillance Committee of Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Clinical Microbiology in 2009: General view of the pathogens' antibacterial susceptibility' [J Infect Chemother 18 (2012) 609–620]

Autor: Akira Komoto, Akihiko Kawana, Yuji Watanuki, Yasuhiro Katono, Morimasa Yagisawa, Jun-ichi Kadota, Mitsuhiro Okazaki, Kazuhiko Ogasawara, Tadahiro Nakamura, Hideki Ikeda, Kiyoshi Negayama, Makoto Kudo, Naoto Koashi, Masao Kuwabara, Takayuki Ezaki, Hideaki Hanaki, Hiroshi Takahashi, Yoshisaburo Takahashi, Shoichi Sasaoka, Yukio Hirako, Yaeko Watanabe, Susumu Nakanowatari, Hiroshige Mikamo, Yoshimi Sato, Makoto Miki, Atsuko Sugai, Yasuo Honma, Michinori Terada, Masaki Fujita, Akinori Maruo, Tetsuro Matsumoto, Takeshi Saraya, Katsunori Yanagihara, Naoyuki Miyashita, Nobuyuki Kobayashi, Nobuki Aoki, Keisuke Sunakawa, Yoshio Takesue, Nobuei Watabe, Yoshitomo Morinaga, Yuka Yamagishi, Satoshi Iwata, Shigeru Kohno, Masao Doi, Yoshinobu Ohsaki, Michio Tanaka, Yasunao Wada, Toshikatsu Tsuji, Kunio Nakanishi, Mariko Takaya, Tetsuya Matsumoto, Shoichi Onodera, Yasuko Aoki, Akira Watanabe, Rikizo Hattori, Kyoichi Totsuka, Kazuhiro Tateda, Tomotaro Wakamura, Kenji Uno, Katsu Saionji, Kazufumi Hiramatsu, Junko Sato, Tsuneo Kozuki, Noriko Mitsuno, Keiichi Mikasa, Yoshio Kobayashi, Kohei Morita, Hiroaki Takeda, Aikichi Iwamoto, Naoki Miyazawa, Yoshihito Niki, Toyoko Oguri, Shinya Kusachi, Mutsuko Utagawa, Sakura Aso, Kei Kasahara, Tetsuro Muratani, Yasuhito Honda, Satomi Shimizu, Hiroki Tsukada, Yumiko Imai, Yukinori Kurokawa, Jin Takasaki, Shinichi Minamitani, Michi Shoji, Junichi Honda, Hisami Konosaki, Reiko Sano, Hajime Goto, Daisuke Kurai, Shigeru Ehara

Publikováno v: Journal of Infection and Chemotherapy. 21:78-80

Akira Watanabe , Katsunori Yanagihara a, b, , Tetsuya Matsumoto , Shigeru Kohno a, , Nobuki Aoki a, , Toyoko Oguri , Junko Sato , Tetsuro Muratani , Morimasa Yagisawa , Kazuhiko Ogasawara , Naoto Koashi , Tsuneo Kozuki , Akira Komoto , Yoshisaburo Ta

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::710e34466602866a69ca578f37ff4a8e
https://doi.org/10.1016/j.jiac.2014.11.004

walK and clpP Mutations Confer Reduced Vancomycin Susceptibility in Staphylococcus aureus▿

Autor: Akira Komoto, Longzhu Cui, Yukiko Watanabe, Mitsutaka Shoji, Risa Iizuka, Tomomi Hishinuma, Hui Min Neoh, Keiichi Hiramatsu

Vancomycin-intermediate Staphylococcus aureus (VISA) is generated from vancomycin-susceptible Staphylococcus aureus by multiple spontaneous mutations. We previously reported that sequential acquisition of mutations in the two-component regulatory sys

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3cbb197d87bb97e2b41616ee574a6ac
https://europepmc.org/articles/PMC3147622/